Skin Cancer
Finding a skin cancer early matters. Your dermatologist and transplant team choose the treatment that fits the type and location of the cancer.
AI Summary Skin cancer is the most common cancer after liver transplant, accounting for about 40% of new cancers, which occur at 2 to 3 times the rate of healthy people the same age and sex.
Medically reviewed.
A malignancy is a cancer. After a liver transplant, your risk of developing a new cancer is higher than it is for people of the same age and sex who have not had a transplant. Overall, the risk is about 2 to 3 times higher. The main reason is that anti-rejection medicines (immunosuppressants) lower your immune system's ability to find and clear abnormal cells. They also raise the risk of cancers caused by viruses, such as human papillomavirus (HPV) and Epstein-Barr virus (EBV).
Skin cancer is the most common type. Lymphoma, cancers linked to viruses, and a return of liver cancer are also possible. Your own risk depends on your age, lifestyle, health history, and the strength of your medicine regimen. Most of these cancers can be found early with regular checks, such as a yearly skin exam, and many risks can be lowered. A higher risk does not mean you will get cancer.
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
About Malignancy Risk
Cancer after a liver transplant can be new (doctors call this de novo) or a return of a cancer you had before. Your immunosuppressants are a main reason the risk rises. They lower your immune system's ability to find abnormal cells, and they raise the risk of cancers caused by viruses, such as human papillomavirus (HPV) and Epstein-Barr virus (EBV).
Overall, the risk of a new cancer is about 2 to 3 times that of healthy people of the same age and sex. Your own risk depends on your age, lifestyle, health history, and how strong your immunosuppressant regimen is.
Early cancers often cause no symptoms, which is why scheduled exams and tests matter. Still, know the signs below and report changes early.
How Cancers Are Found
Your team watches for cancer with physical exams and screening tests. Schedules vary, so follow the plan your own team gives you.
Keep every exam, lab draw, and imaging visit, even when you feel well. Finding a cancer early gives you more treatment options.
Care and Treatment
Treatment depends on the type of cancer, where it is, and how far it has spread. Your transplant team and cancer specialists make these decisions with you.
Finding a skin cancer early matters. Your dermatologist and transplant team choose the treatment that fits the type and location of the cancer.
If EBV is found in the blood, the main step is to lower your immunosuppression so your body can control the virus. Standard antivirals are not recommended for EBV. If PTLD develops, first-line treatments may include rituximab or chemotherapy. Never lower or stop your medicines on your own.
A liver cancer that returns is watched closely, and your team plans care around it. See our page on hepatocellular carcinoma for more.
Your team may balance cancer treatment against the need to protect your new liver. This can include adjusting your immunosuppressant regimen.
Follow-up visits, screening tests, and lab work continue even when you feel well. They let your team catch changes early.
Why It Happens
Cancer after transplant can come from your health history, your medicines, and infections that your immune system can no longer control as well.
You cannot change every risk factor, but you can change several. Tell your team about your history and your lifestyle, so they can tailor your screening.
Prevention
Small daily habits lower your risk and help your team catch problems early.
Have a full-body skin exam every year, and check in with a dermatologist. Use sun avoidance, sunscreen, and protective clothing. Skin cancers after transplant are common but often preventable.
Take each immunosuppressant exactly as prescribed. Never stop or change a dose without talking to your team. Ask your team whether your regimen can be kept as low as safely possible.
Keep up with cervical, colorectal, prostate, and lung screening as your team advises. Share your smoking and alcohol history.
Avoid tobacco and limit alcohol. Both are known cancer risks.
Keep a skin diary. Note new rashes or spots and take photos. Show them to your nurse or dermatologist at each visit.
Daily Habits After Transplant
Living with a transplanted liver means treating your daily routine as part of your care. Consistent medicine, regular screening, sun protection, and open talks with your team all work together to lower your risk and catch problems early.
Food is part of that routine. Choose meals that feed your liver gently and consistently: three balanced meals each day, with familiar foods you enjoy. A higher cancer risk does not mean you will get cancer. Most recipients do well. What matters is staying consistent and telling your team about anything that feels different.
Habits That Support Your New Liver
Common Questions
Yes, somewhat. The risk of a new cancer after liver transplant is about 2 to 3 times that of healthy people of the same age and sex. The main reason is your anti-rejection medicine. It lowers your immune system's ability to find and clear abnormal cells, and it raises the risk of cancers caused by viruses such as HPV and EBV. Your risk also depends on your age, your smoking and alcohol history, whether you have diabetes, and how strong your immunosuppressant regimen is. A higher risk does not mean you will get cancer. It means regular screening and sun protection matter more for you.
Skin cancer is the most common cancer after liver transplant and makes up about 40% of new cancers. Non-melanoma types, such as squamous cell and basal cell carcinoma, are more common, especially in older recipients. Guidelines support a full-body skin exam every year, along with advice on avoiding the sun and protecting your skin. Use sunscreen and protective clothing, and keep a skin diary with photos of new spots or rashes. Show them to your nurse or dermatologist at each visit. Skin cancers after transplant are common, but they are often preventable and easier to treat when found early.
PTLD stands for post-transplant lymphoproliferative disorder. It is a condition in which B-cells, a type of white blood cell, grow out of control and can become cancerous. It is linked to Epstein-Barr virus (EBV), which infects a large share of people and is found in most early B-cell PTLD cases. PTLD affects about 2% to 4% of liver transplant recipients. Non-Hodgkin lymphoma is more common in males, in younger recipients, and soon after transplant. Possible signs include fever, chills, extreme fatigue, muscle aches, swollen lymph nodes, and nausea, vomiting, or diarrhea. Call your team if you notice these.
It can, but it does not always. If you had hepatocellular carcinoma before your transplant, it returns in about 10% to 18% of people, usually within two years. For that reason, your team may monitor you more closely in the first years. People who never had liver cancer are not in this group. Keep every follow-up visit and imaging appointment, and tell your team if you have new symptoms. You can read more on our hepatocellular carcinoma page.
Your team uses a mix of exams and tests. You should have a full-body skin exam every year. Cervical screening is recommended every year during the first years after transplant. Colorectal screening generally follows the same intervals as for the general population, but people with primary sclerosing cholangitis need it more often. Men ages 55 to 70 commonly continue yearly PSA testing, and people with a significant smoking history may need low-dose CT lung screening. Routine EBV blood tests are not for everyone and are usually reserved for higher-risk groups. Ask your team which tests apply to you and when.
Treatment depends on the cancer type, where it is, and how far it has spread. Your transplant team and cancer specialists plan it together. For lymphoma and PTLD, the main step when EBV is found in the blood is to lower your immunosuppression so your body can control the virus. Standard antivirals are not recommended for EBV. If PTLD develops, first-line treatments may include rituximab or chemotherapy. Your team may need to balance cancer treatment against protecting your new liver. Never lower or stop your medicines on your own.
Call your transplant team about any new or worsening symptom. Do not wait for your next appointment. This includes a new or changing spot on your skin, fever or chills, extreme fatigue, muscle aches, swollen lymph nodes, nausea, vomiting, diarrhea, or any change that feels different from your usual baseline. Keep a notebook or phone app of symptoms, questions, and photos of skin changes, and bring it to each visit. Keep every lab and clinic appointment, even when you feel fine, because early cancers often cause no symptoms.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.